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1. INTRODUCTION {#joa312215-sec-0005}
===============

Hypertrophic cardiomyopathy (HCM) is a complex genetically transmitted disease with variable clinical expression.[1](#joa312215-bib-0001){ref-type="ref"}, [2](#joa312215-bib-0002){ref-type="ref"} Since its initial presentation more than 50 years ago, HCM is considered as a major cause of sudden cardiac death (SCD), heart failure (HF), AF and stroke.[3](#joa312215-bib-0003){ref-type="ref"}, [4](#joa312215-bib-0004){ref-type="ref"} HCM often takes insidious clinical course, and early detection may be beneficial for prevention of significant morbidity and mortality in high‐risk patients. Consequently, there is an ever growing effort to study the frequency of HCM in the general population.[5](#joa312215-bib-0005){ref-type="ref"}

However, most of the natural history data of HCM are derived from regional cohorts,[6](#joa312215-bib-0006){ref-type="ref"}, [7](#joa312215-bib-0007){ref-type="ref"}, [8](#joa312215-bib-0008){ref-type="ref"} and thus comprehensive assessment of disease in various age groups and patients with different ethnicity remains incomplete. More importantly, there is paucity of epidemiological information with regards to HCM and concomitant arrhythmia, which is the main trigger for mortality in these patients. To fill this knowledge gap, we studied the temporal trends in HCM related hospitalization in the United States (US), while keeping the main focus on patients with HCM and associated burden of arrhythmia. This study also covers the important aspects of disease burden in terms of inhospital mortality, comorbidities, length of hospital stay (LOS) and cost of caring during the hospitalization.

2. METHODS {#joa312215-sec-0006}
==========

We acquired data using Nationwide Inpatient Sample (NIS) from the year 2003 to 2014. NIS is the largest database of hospital inpatient stays in the United States (US), generated by the Agency for Healthcare Research and Quality (AHRQ). This database accounts for approximately up to 8 million discharges each year; and has been used in the past for ascertainment, tracking, and assessment of national trends in health care provision, access, major procedures related outcomes, disparity of care, hospitalizations rates, and analysis of health care economics and quality control measures.[9](#joa312215-bib-0009){ref-type="ref"}, [10](#joa312215-bib-0010){ref-type="ref"}, [11](#joa312215-bib-0011){ref-type="ref"}, [12](#joa312215-bib-0012){ref-type="ref"} Each individual hospitalization in NIS is deidentified and kept as a unique entry with one primary discharge diagnosis and \< 29 secondary diagnoses during that hospitalization. Internal validity of the database is maintained by performing annual data quality assessments, while the external validity of this database is evaluated by comparing with the National Hospital Discharge Survey from the National Center for Health Statistics, American Hospital Association Annual Survey Database, and the MedPAR inpatient data from the Centers for Medicare and Medicaid Services.[13](#joa312215-bib-0013){ref-type="ref"}

In this cross sectional study, we studied all hospitalizations from 2003 to 2014 using the ICD‐9 codes 425.1 and 425.11 for hypertrophic cardiomyopathy (HCM) in all diagnosis fields. We included all the subjects ≥ 18 years. To study the baseline characteristics, we excluded subjects with missing information, such as, age, gender, admission or discharge date, and inpatient mortality status. For the purpose of potential confounder identification, both patient‐ and hospital‐level variables were included. The severity of comorbid conditions was defined using Deyo modification of Charlson comorbidity index[14](#joa312215-bib-0014){ref-type="ref"} (Table [S1](#joa312215-sup-0001){ref-type="supplementary-material"}). This index contains 17 comorbid conditions with differential weights. The score ranges from 0 to 33, with higher scores corresponding to greater burden of comorbid diseases. We identified heart failure and renal failure using "cm\_" variables provided by NIS. We defined arrhythmias as codiagnosis of any of any of these specific rhythm disorders: Atrial fibrillation, Atrial Flutter, Supraventricular tachycardia, Ventricular Fibrillation/Flutter, or Ventricular Tachycardia. These specific arrhythmias were identified using ICD‐9 codes in any diagnosis field (Table [S2](#joa312215-sup-0002){ref-type="supplementary-material"}). We defined teaching hospitals if they were accredited with an American Medical Association approved residency program, were a member of the Council of Teaching Hospitals, or had a full‐time equivalent intern and resident‐to‐patient ratio of 0.25. We estimated the cost of hospitalizations by merging NIS data with cost to‐ charge ratios available from the Healthcare Cost and Utilization Project. The cost of each inpatient stay was calculated by multiplying the total hospital charge with the cost to charge ratio. The adjusted cost for each year was calculated in terms of the 2011 cost after adjusting for inflation according to the latest consumer price index data released by the US government on January 16, 2013.[15](#joa312215-bib-0015){ref-type="ref"}, [16](#joa312215-bib-0016){ref-type="ref"} This methodology is in line with prior studies.[17](#joa312215-bib-0017){ref-type="ref"} Exponential trend line was used to represent the trend in total cost from 2003 to 2014.

All analyses were conducted using [sas]{.smallcaps} 9.4 (SAS Institute Inc., Cary, North Carolina), which accounts for the complex survey design and clustering. Since NIS represents a 20% stratified random sample of US hospitals, analyses were performed using hospital‐level discharge weights provided by the NIS, to obtain national estimates of HCM hospitalization. For categorical variables like annual change in HCM hospitalization rate and inhospital mortality, we used Chi‐square test of trend for proportions using the Cochrane Armitage test.[18](#joa312215-bib-0018){ref-type="ref"} Differences between categorical variables were tested using the chi‐square test, and differences between continuous variables were tested using the student\'s *t* test. All the analyses were performed at 5% significance level.

3. RESULTS {#joa312215-sec-0007}
==========

3.1. HCM hospitalization, demographics and comorbidities {#joa312215-sec-0008}
--------------------------------------------------------

A total of 225 618 hospitalizations with HCM as the discharge diagnosis were analyzed from 2003 to 2014 (59.72% to ≥ 65 years of age, 63.4% females, 62.1% whites). Among which, 90 940 had coexisting arrhythmias. Compared to HCM patients without arrhythmias, those with arrhythmias were older (64.4% vs 56.6% ≥ 65 years of age), had higher burden of comorbidities (42.78% vs 40.36% with charlson comorbidity index ≥ 2), consisted of higher proportion of Males (40.55% vs 33.98%) and White subjects (67.32% vs 58.56%). Those with arrhythmias had higher median household income (52.6% vs 47.7% above 50th percentile), and Medicare/Medicaid coverage (71.6% vs 68.9%). Additionally, subjects with arrhythmias were more frequently admitted to large hospitals (67.4% vs 66.3%) with teaching affiliation (56.2% vs 54.9%), had higher proportion of admissions over weekend (19.9% vs 18.4%) and were admitted emergently (80% vs 78.4 %). Significantly higher prevalence of heart failure (44.7% vs 29.2%) and renal failure (13.9% vs 12.4%) were noted among HCM patients with arrhythmias. Our study noted higher mortality among patients with arrhythmias compared to those without arrhythmias (4.6% vs 2.9%). \[*P*‐value significant for all values, Table [1](#joa312215-tbl-0001){ref-type="table"}\].

###### 

Baseline characteristics of HCM patient with and without arrythmias

                                                                                                         Arrhythmia                                
  ------------------------------------------------------------------------------------------------------ ------------- ------------- ------------- ---------
  Index hospitalization with HOCM                                                                        134 678       90 940        225 618       \<0.001
  Patient level variables                                                                                                                          
  Age, y (%)                                                                                                                                       \<0.001
  18‐49                                                                                                  18.2          12.1          15.8           
  50‐64                                                                                                  25.3          23.5          24.5           
  65‐79                                                                                                  31.6          35.9          33.4           
  ≥80                                                                                                    24.9          28.5          26.4           
  Race (%)                                                                                                                                         \<0.001
  White                                                                                                  58.6          67.3          62.1           
  Black                                                                                                  14.0          8.4           11.8           
  Hispanics                                                                                              4.3           3.7           4.1            
  Other                                                                                                  23.1          20.6          22.1           
  Gender (%)                                                                                                                                       \<0.001
  Male                                                                                                   34.0          40.6          36.6           
  Female                                                                                                 66.0          59.5          63.4           
  Deyo/Charlson Score[b](#joa312215-note-0004){ref-type="fn"} (%)                                                                                  \<0.001
  0                                                                                                      30.3          26.6          28.8           
  1                                                                                                      29.4          30.7          29.9           
  ≥2                                                                                                     40.4          42.8          41.3           
  Comorbidities (%)                                                                                                                                 
  Codiagnosis of Heart failure[a](#joa312215-note-0003){ref-type="fn"}                                   29.2          44.7          35.4          \<0.001
  Renal failure/Electrolyte abnormality[a](#joa312215-note-0003){ref-type="fn"}                          12.4          13.9          13.0          \<0.001
  Median household income category for patient\'s zip code[c](#joa312215-note-0005){ref-type="fn"} (%)                                             \<0.001
  1\. 0‐25th percentile                                                                                  26.5          22.0          24.7           
  2\. 26‐50th percentile                                                                                 25.8          25.4          25.7           
  3\. 51‐75th percentile                                                                                 23.8          25.2          24.4           
  4\. 76‐100th percentile                                                                                23.9          27.4          25.3           
  Primary Payer (%)                                                                                                                                \<0.001
  Medicare/ Medicaid                                                                                     68.9          71.6          70.0           
  Private including HMO[f](#joa312215-note-0008){ref-type="fn"}                                          25.0          24.4          24.8           
  Self‐pay/no charge/other                                                                               5.9           3.9           5.1            
  Hospital characteristics                                                                                                                         
  Hospital bed size[d](#joa312215-note-0006){ref-type="fn"} (%)                                                                                    \<0.001
  Small                                                                                                  11.2          11.0          11.1           
  Medium                                                                                                 22.5          21.6          22.1           
  Large                                                                                                  66.3          67.4          66.8           
  Hospital teaching status[e](#joa312215-note-0007){ref-type="fn"} (%)                                                                             \<0.001
  NonTeaching                                                                                            44.8          43.6          44.3           
  Teaching                                                                                               54.9          56.2          55.4           
  Admission type (%)                                                                                                                               \<0.001
  NonElective                                                                                            78.4          80.0          79.0           
  Elective                                                                                               21.7          20.0          21.0           
  Admission day (%)                                                                                                                                \<0.001
  Weekdays                                                                                               81.6          80.1          81.0           
  Weekend                                                                                                18.4          19.9          19.0           
  In hospital Mortality (%)                                                                              2.9           4.6           3.6           \<0.001
  Length of stay (Mean ± Std dev), days                                                                  5.46 ± 0.04   6.53 ± 0.06   5.89 ± 0.04   \<0.001

Abbreviation: Iqr, Interquartile range.

Variables are AHRQ comorbidity measures.

Charlson/Deyo Comorbidity index (CCI) was calculated as per Deyo classification.

Represents a quartile classification of the estimated median household income of residents in the patients ZIP Code, derived from ZIP Code‐demographic data obtained from Claritas. The quartiles are identified by values of 1 to 4, indicating the poorest to wealthiest populations. Because these estimates are updated annually, the value ranges vary by year. <https://www.hcup-us.ahrq.gov/db/vars/zipinc_qrtl/nrdnote.jsp>

The bed size cutoff points divided into small, medium, and large have been done so that approximately one‐third of the hospitals in a given region, location, and teaching status combination would fall within each bed size category. <https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nrdnote.jsp>

A hospital is considered to be a teaching hospital if it has an AMA‐approved residency program, is a member of the Council of Teaching Hospitals (COTH) or has a ratio of full‐time equivalent interns and residents to beds of 0.25 or higher. <https://www.hcup-us.ahrq.gov/db/vars/hosp_ur_teach/nrdnote.jsp>

HMO: Health Maintenance Organization.
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3.2. Trends of arrhythmia in HCM patients {#joa312215-sec-0009}
-----------------------------------------

In a total of 90 940 HCM patients with arrhythmia, there was an increase in the number of hospitalizations from 7784 in 2003 to 8380 in 2014 (relative increase 10.5%). The magnitude of rise in arrhythmia was observed in the following age groups **(**Table [2](#joa312215-tbl-0002){ref-type="table"} **)** in descending order: ≥ 80 years (relative increase 23.2%, *P* \< 0.001), 50--64 years (relative increase 20%, *P* \< 0.001), 65--79 years (relative increase 19%, *P* \< 0.001) and 18--49 (relative increase 17.1%, *P* \< 0.001). The relative rates of increment over the years were higher for males (relative increase 22.19%, *P* \< 0.001) and Hispanics (relative increase 40.1%, *P* \< 0.001) among gender and race groups respectively. Our study noted a higher rise in the prevalence of arrhythmias among patients with charlson comorbidity index ≥ 2 (relative increase 20.47%), lower socioeconomic class (relative increase 25.75%), no insurance coverage relative increase 67.25%), admitted to nonteaching facilities (relative increase 19.52%) or in mid‐west (relative increase 22.42%). HCM patients admitted over weekday or having nonurgent hospitalizations had higher increment in arrhythmias compared to those who had weekend or urgent admissions respectively. HCM patients with renal failure witnessed greater rise in prevalence of compared to those without renal failure. (Relative increase 50.64%) \[*P*‐value significant for all trends\].

###### 

Trend of prevalence of any arrhythmia in hospitalized HCM patients

                                                                     2003     2004     2005     2006     2007     2008     2009     2010     2011     2012     2013     2014     Overall   P‐trend   Relative change
  ------------------------------------------------------------------ -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- --------- -----------------
  Patients with HOCM (N)                                             20 494   18 841   18 954   19 852   17 770   18 191   19 611   18 401   18 749   17 765   18 045   18 945   225 618             ‐6.5
  Patients with Arrhythmias in HOCM Population (N)                   7784     7374     7003     7649     6857     6874     8102     7344     7724     7770     8080     8380     90 940              10.5
  Age, Y (%)                                                                                                                                                                                         
  18--49                                                             28.4     29.6     29.0     28.1     27.2     30.2     33.5     32.9     35.0     31.2     33.6     33.3     31.0      \<0.001   17.1
  50--64                                                             34.5     37.9     34.9     37.0     37.1     37.2     39.9     36.7     39.7     44.0     39.1     42.6     38.6      \<0.001   20.0
  65--79                                                             41.3     42.7     39.5     39.7     43.8     39.4     44.5     44.4     41.7     48.1     48.8     47.8     43.4      \<0.001   19.0
  ≥80                                                                40.9     40.7     39.8     44.3     40.3     40.6     44.5     42.3     46.1     45.6     52.8     48.0     43.6      \<0.001   23.2
  Race (%)                                                                                                                                                                                           
  White                                                              42.1     43.2     39.4     42.1     42.3     40.3     45.2     42.8     44.2     46.6     47.4     47.5     43.7      \<0.001   15.1
  Black                                                              28.2     29.2     23.1     29.2     23.5     29.4     24.9     30.7     27.6     30.2     36.3     29.6     28.8      \<0.001   18.9
  Hispanics                                                          29.7     33.6     31.8     41.0     31.0     36.5     32.8     31.8     42.1     36.7     39.5     49.5     36.8      \<0.001   40.1
  Other                                                              33.5     35.0     36.3     35.5     37.3     35.5     39.9     36.2     40.6     42.8     41.6     43.8     37.4      \<0.001   28.1
  Gender (%)                                                                                                                                                                                         
  Male                                                               41.3     42.1     41.6     40.5     42.4     42.1     45.6     44.2     48.4     50.8     47.7     48.2     44.6      \<0.001   22.2
  Female                                                             36.4     37.6     34.4     37.4     36.3     35.4     38.7     37.3     37.0     39.5     42.9     41.8     37.8      \<0.001   15.5
  Deyo/Charlson Score ^b^ (%)                                                                                                                                                                        
  0                                                                  32.9     37.6     35.7     34.9     34.7     35.7     41.4     35.9     39.0     41.2     39.2     40.8     37.2      \<0.001   19.9
  1                                                                  40.8     39.1     38.5     41.4     42.5     39.7     41.8     40.0     41.3     43.4     44.8     44.9     41.3      \<0.001   11.8
  ≥2                                                                 40.0     40.7     36.5     39.2     38.7     37.9     40.9     42.4     42.4     45.3     47.4     45.5     41.7      \<0.001   20.5
  Median household income category for patient\'s zip code ^c^ (%)                                                                                                                                   
  1\. 0‐25th percentile                                              32.1     33.0     35.3     30.7     37.3     33.8     37.9     35.2     36.4     39.1     41.1     40.1     36.0      \<0.001   25.8
  2\. 26‐50th percentile                                             37.4     38.5     35.3     40.1     37.1     35.5     40.8     39.4     42.6     43.4     45.9     44.2     40.0      \<0.001   22.9
  3\. 51‐75th percentile                                             38.4     43.9     35.3     39.5     38.7     39.6     42.1     40.4     44.4     44.0     46.0     48.7     41.8      \<0.001   22.6
  4\. 76‐100th percentile                                            44.7     41.4     35.3     44.1     41.9     41.3     44.5     45.6     42.3     48.7     46.6     45.2     43.8      \<0.001   12.9
  Primary Payer (%)                                                                                                                                                                                  
  Medicare/ Medicaid                                                 39.5     40.8     38.2     39.1     39.4     38.0     42.0     39.7     42.2     44.6     46.5     44.9     41.2      \<0.001   17.2
  Private including HMO                                              34.8     36.5     36.3     39.8     39.4     38.4     41.3     42.4     40.0     42.6     41.6     43.0     39.7      \<0.001   21.3
  Self‐pay/no charge/other                                           23.9     26.3     21.1     24.4     23.8     31.5     34.7     30.7     33.6     37.2     36.7     36.9     30.5      \<0.001   67.3
  Hospital characteristics                                                                                                                                                                           
  Hospital bed size ^d^ (%)                                                                                                                                                                          
  Small                                                              42.2     37.7     33.0     38.4     36.8     39.3     46.1     39.4     39.9     42.2     40.7     42.4     39.9      \<0.001   10.5
  Medium                                                             34.0     41.8     32.5     37.6     38.1     36.6     38.7     40.2     42.7     43.5     44.4     43.6     39.4      \<0.001   27.2
  Large                                                              38.7     38.5     38.9     39.0     39.1     37.9     41.7     39.9     40.9     44.1     45.6     45.0     40.7      \<0.001   18.2
  Hospital teaching status^e^ (%)                                                                                                                                                                    
  NonTeaching                                                        36.3     39.5     37.2     38.9     39.8     37.4     40.0     40.9     39.7     42.7     45.3     43.9     39.7      \<0.001   19.5
  Teaching                                                           39.9     38.8     36.6     38.3     37.5     38.3     42.6     39.0     42.2     44.4     44.5     44.3     40.9      \<0.001   17.5
  Admission type (%)                                                                                                                                                                                 
  NonElective                                                        38.5     40.0     38.2     38.7     38.9     38.1     41.6     40.3     41.8     44.0     45.6     44.8     40.8      \<0.001   18.2
  Elective                                                           35.8     36.2     32.3     37.8     37.4     36.5     40.4     38.6     39.3     43.2     41.7     42.2     38.4      \<0.001   22.7
  Admission Day (%)                                                                                                                                                                                  
  Weekdays                                                           37.5     38.7     36.1     37.8     38.7     37.3     40.5     39.8     40.9     43.3     44.6     43.8     39.9      \<0.001   19.9
  Weekend                                                            40.3     41.0     40.6     41.3     38.2     39.8     45.4     40.5     42.4     45.8     45.7     46.1     42.2      \<0.001   15.3
  Comorbidities (%)                                                                                                                                                                                  
  Heart failure^a^                                                                                                                                                                                   
  Yes                                                                50.1     48.8     47.7     48.0     51.8     46.6     49.2     50.5     51.0     53.8     56.7     54.3     50.8      \<0.001   13.4
  No                                                                 31.7     34.2     31.3     33.7     32.1     33.5     37.2     33.9     35.9     37.8     36.7     37.4     34.5      \<0.001   18.5
  Renal failure/Electrolyte abnormality^a^                                                                                                                                                           
  Yes                                                                37.4     41.0     32.4     40.9     40.3     38.0     41.1     41.4     43.6     45.0     51.4     49.6     43.1      \<0.001   50.6
  No                                                                 37.8     39.0     37.3     38.2     38.3     37.8     41.4     39.7     40.7     43.5     43.3     43.1     39.9      \<0.001   16.3

a, c, d, e, f, g = Same as Table [1](#joa312215-tbl-0001){ref-type="table"}.
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3.3. Trends of specific arrhythmias among HCM patients {#joa312215-sec-0010}
------------------------------------------------------

Among HCM subjects, 40.3% of patients had a wide range of arrhythmia at presentation. Specifically, AF (34.1%) was the most commonly reported arrhythmia followed by ventricular tachycardia (6.7%) and atrial flutter (4.4%). Across all the arrhythmias, AFL showed the maximum increase in prevalence across the study period (relative increase 65.7%, *P* \< 0.001), followed by VT (relative increase 30.1%, *P* \< 0.001), VT/VFL (relative increase 26.7%, *P* \< 0.001) and AF (relative increase 22.1%, *P* \< 0.001) (Figure [1](#joa312215-fig-0001){ref-type="fig"}).

![Trends of overall and specific arrhythmias in hypertrophic cardiomyopathy (HCM) patients](JOA3-35-612-g001){#joa312215-fig-0001}

3.4. Mortality trends among HCM patients with arrhythmias {#joa312215-sec-0011}
---------------------------------------------------------

Although inhospital mortality was higher in HCM patients with concomitant arrhythmia, there was a significant decline in mortality in patients with arrhythmia from 6.2 % in 2003 to 3.4 % in 2014 (relative decrease 22.82%, *P*‐trend \< 0.001). Mortality rate was higher in patients ≥ 80 years age (7.4%), females (5.5%), and black population (4.64%) among HCM patients with arrhythmias. Mortality was slightly lesser in teaching hospitals than nonteaching hospitals (4.4% vs 4.8%, *P* \< 0.001); conversely, mortality rates were higher in West region hospitals (5.6%) and in patients with Medicare/Medicaid insurance (5.3%). Mortality was higher for patients carrying HF (9.5%) and renal failure (8.1%) as comorbid diagnosis compared to those who did not have these comorbidities. Trends of mortality in specific subgroups of HCM patients with arrhythmias are shown in Table [3](#joa312215-tbl-0003){ref-type="table"}.

###### 

Trends of mortality based on demographics and comorbidities of hospitalized HCM patients

                                                                    2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014   Overall   *P*‐value   relative change
  ----------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ --------- ----------- -----------------
  Patients with Arrhythmias and HOCM                                7784   7374   7003   7649   6857   6874   8102   7344   7724   7770   8080   8380   90 940    \<0.001     10.5
  Overall mortality in HOCM (%)                                                                                                                                               
  Patients without arrhythmia                                       3.5    3.0    2.6    2.2    2.9    3.9    2.7    3.2    3.2    2.7    2.5    2.2    2.9       0.001       ‐14.2
  Patients with Arrhythmia                                          6.2    5.3    4.0    4.5    4.6    4.1    5.3    4.7    5.0    3.9    4.3    3.4    4.6       \<0.001     ‐22.8
  Age, y (%)                                                                                                                                                                  
  18--49                                                            5.8    0.6    1.7    1.7    0.6    0.5    1.4    2.1    2.7    0.6    3.0    2.1    1.9       0.239       ‐10.5
  50--64                                                            1.4    3.0    2.2    4.2    2.2    2.3    3.6    2.2    3.3    2.8    2.2    2.7    2.7       0.539       21.8
  65--79                                                            5.6    5.8    3.9    3.7    5.0    3.1    5.5    4.9    4.1    4.0    4.7    3.1    4.5       \<0.001     ‐22.6
  ≥80                                                               9.7    8.0    6.1    6.5    7.6    8.2    8.7    8.2    8.5    6.4    5.9    5.1    7.4       \<0.001     ‐21.4
  Race (%)                                                                                                                                                                    
  White                                                             5.7    4.4    3.7    4.4    4.8    3.8    5.6    4.8    5.2    4.0    4.0    3.3    4.5       \<0.001     ‐14.9
  Black                                                             3.6    7.1    6.3    6.3    4.7    6.0    2.9    5.4    4.4    2.1    5.2    3.0    4.6       0.003       ‐67.6
  Hispanics                                                         13.1   5.0    5.2    1.9    0.0    0.0    8.2    0.0    4.4    3.7    4.0    4.4    4.0       0.066       ‐27.9
  Other                                                             7.4    7.0    4.1    4.4    4.7    5.0    4.5    5.0    4.2    4.2    4.9    4.3    5.1       \<0.001     ‐27
  Gender (%)                                                                                                                                                                  
  Male                                                              5.2    3.0    2.3    3.4    3.8    2.9    3.7    3.3    3.3    2.2    3.2    3.3    3.3       0.009       ‐15.3
  Female                                                            6.7    6.6    5.1    5.1    5.2    4.9    6.4    5.7    6.2    5.2    5.0    3.5    5.5       \<0.001     ‐23.2
  Deyo/Charlson Score^b^ (%)                                                                                                                                                  
  0                                                                 2.3    2.8    1.8    1.3    1.6    1.5    2.1    1.6    1.5    0.8    2.4    1.1    1.8       \<0.001     ‐38.1
  1                                                                 6.0    3.9    3.4    3.1    5.5    4.2    4.1    3.0    3.5    2.2    3.6    3.0    3.8       \<0.001     ‐32.4
  ≥2                                                                9.3    8.9    6.5    8.1    5.9    5.7    8.4    7.5    7.7    6.3    5.4    4.6    6.9       \<0.001     ‐32.8
  Median household income category for patient\'s zip code^c^ (%)                                                                                                             
  1\. 0‐25th percentile                                             6.9    3.4    6.1    5.0    4.3    4.5    5.0    4.5    4.9    4.5    2.8    2.7    4.5       \<0.001     ‐34.9
  2\. 26‐50th percentile                                            7.8    5.5    4.0    3.8    5.3    4.7    5.4    6.0    5.7    3.5    4.5    3.4    4.9       \<0.001     ‐23.7
  3\. 51‐75th percentile                                            5.8    5.6    4.4    4.5    5.2    3.6    6.8    3.7    6.2    3.3    5.6    3.4    4.9       0.021       ‐18.0
  4\. 76‐100th percentile                                           4.4    5.8    1.5    4.4    4.1    4.0    3.6    5.0    3.0    4.4    4.1    3.9    4.0       0.526       ‐4.8
  Primary payer (%)                                                                                                                                                           
  Medicare/ Medicaid                                                6.7    5.9    5.0    5.0    5.6    5.0    6.2    5.6    6.2    4.1    4.9    3.8    5.3       \<0.001     ‐23.7
  Private including HMO ^x^                                         3.6    3.7    0.8    2.9    1.7    2.1    3.6    2.9    1.5    2.3    2.5    2.3    2.5       0.103       ‐16.8
  Self‐pay/no charge/other                                          11.7   2.2    5.3    3.9    5.4    1.4    2.2    2.9    3.4    8.6    3.6    2.9    4.1       0.169       ‐23.1
  Hospital characteristics                                                                                                                                                    
  Hospital bed size^d^ (%)                                                                                                                                                    
  Small                                                             7.5    3.1    2.5    3.8    3.5    4.9    6.9    1.3    7.6    2.6    2.5    2.8    4.1       0.001       ‐21.7
  Medium                                                            4.5    4.6    4.2    5.3    4.2    4.0    4.3    8.1    5.4    4.3    5.7    2.8    4.7       0.868       3.6
  Large                                                             6.4    5.9    4.1    4.3    4.9    4.0    5.2    4.3    4.4    3.9    4.1    3.8    4.6       \<0.001     ‐28.1
  Hospital teaching status^e^ (%)                                                                                                                                             
  NonTeaching                                                       6.4    5.3    3.3    4.6    4.7    4.2    6.3    5.2    5.4    4.2    4.4    3.3    4.8       0.008       ‐17.4
  Teaching                                                          5.9    5.3    4.8    4.4    4.5    4.0    4.5    4.2    4.7    3.7    4.2    3.4    4.4       \<0.001     ‐28.3
  Admission type (%)                                                                                                                                                          
  NonElective                                                       6.9    5.8    4.6    4.9    4.9    4.4    5.4    5.1    5.1    4.3    4.3    3.4    4.9       \<0.001     ‐29.0
  Elective                                                          3.3    3.2    1.2    2.4    3.4    2.7    4.6    3.0    4.2    2.2    4.2    3.5    3.2       0.018       32.6
  Admission day (%)                                                                                                                                                           
  Weekdays                                                          6.0    5.2    4.2    4.0    4.8    4.0    5.0    3.8    4.3    3.5    4.7    3.5    4.4       \<0.001     ‐23.2
  Weekend                                                           6.9    5.8    3.2    6.1    4.0    4.4    6.3    8.2    7.5    5.5    2.3    3.0    5.3       0.002       ‐20.9
  Comorbidities (%)                                                                                                                                                           
  Heart failure^a^                                                                                                                                                            
  No                                                                4.8    4.3    3.1    3.2    3.1    2.6    3.8    3.3    4.4    3.2    3.5    2.6    3.5       \<0.001     ‐17.9
  Yes                                                               14.1   9.9    7.6    10.2   10.2   11.9   12.7   11.0   7.7    7.0    7.0    6.7    9.5       \<0.001     ‐33.2
  Renal failure/Electrolyte abnormality^a^                                                                                                                                    
  No                                                                5.2    3.9    2.2    2.9    3.2    2.5    2.6    2.6    2.3    1.6    1.9    1.4    2.8       \<0.001     ‐50.6
  Yes                                                               11.6   9.8    9.5    8.1    7.5    7.4    10.0   8.5    8.7    7.1    7.0    5.9    8.1       \<0.001     ‐31.9

a, c, d, e, f, g = Same as Table [1](#joa312215-tbl-0001){ref-type="table"}.
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Among specific arrhythmias in HCM patients, highest mortality was observed in patients with VF/VFL (18.3 %), AF and VT (4.5%) and atrial flutter (4.1%).However, there was a gradual reduction in arrhythmia specific mortality, and statistically significant reduction occurred in VF/VFL (relative decrease 44.5%, *P*‐trend \< 0.001) and AF (relative decrease 29.3%, *P*‐trend \< 0.001) (Table [4](#joa312215-tbl-0004){ref-type="table"}).

###### 

Trends of mortality as per specific arrhythmia in hospitalized HOCM patients

  Arrhythmia specific mortality trend (%)                                    2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014   Overall   P‐trend   Relative change
  -------------------------------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ --------- --------- -----------------
  Any arrhythmia[a](#joa312215-note-0012){ref-type="fn"}                                                                                                                             
  Yes                                                                        6.2    5.3    4.0    4.5    4.6    4.1    5.3    4.7    5.0    3.9    4.3    3.4    4.6       \<0.001   ‐22.8
  No                                                                         3.5    3.0    2.6    2.2    2.9    3.9    2.7    3.2    3.2    2.7    2.5    2.2    2.9       \<0.001   ‐14.2
  Atrial fibrillation[a](#joa312215-note-0012){ref-type="fn"}                                                                                                                        
  Yes                                                                        6.2    5.4    4.2    4.9    4.5    3.5    4.7    4.7    4.8    4.1    3.8    3.2    4.5       \<0.001   ‐29.3
  No                                                                         3.7    3.1    2.6    2.2    3.1    4.1    3.3    3.4    3.4    2.7    3.0    2.4    3.1       0.3       ‐8.8
  Atrial Flutter[a](#joa312215-note-0012){ref-type="fn"}                                                                                                                             
  Yes                                                                        4.8    5.4    3.0    3.5    4.6    2.4    4.8    4.9    2.7    4.6    3.6    4.6    4.1       0.753     ‐6.3
  No                                                                         4.5    3.8    3.1    3.1    3.5    4.0    3.7    3.8    3.9    3.1    3.3    2.6    3.5       \<0.001   ‐17.6
  Supraventricular Tachycardia[a](#joa312215-note-0012){ref-type="fn"}                                                                                                               
  Yes                                                                        4.8    3.2    2.2    0.0    4.6    9.1    9.2    5.4    0.0    3.4    2.4    0.0    3.7       0.128     ‐39.1
  No                                                                         4.5    3.9    3.1    3.1    3.5    3.9    3.7    3.8    4.0    3.2    3.3    2.8    3.6       \<0.001   ‐16.2
  Ventricular Fibrillation/Flutter[a](#joa312215-note-0012){ref-type="fn"}                                                                                                           
  Yes                                                                        29.6   23.5   10.3   23.2   25.6   20.2   15.7   9.9    27.6   4.9    20.5   7.1    18.3      \<0.001   ‐44.5
  No                                                                         4.2    3.7    3.1    3.0    3.3    3.8    3.6    3.8    3.7    3.2    3.1    2.7    3.4       \<0.001   ‐15.1
  Ventricular Tachycardia[a](#joa312215-note-0012){ref-type="fn"}                                                                                                                    
  Yes                                                                        5.3    2.9    2.2    3.7    4.7    6.3    7.3    3.0    4.8    4.6    5.0    3.8    4.5       0.123     16
  No                                                                         4.4    4.0    3.2    3.1    3.5    3.8    3.5    3.9    3.8    3.1    3.2    2.7    3.5       \<0.001   ‐19.5

Other primary diagnosis: derived from appropriate ICD 9CM code mentioned in Table [S2](#joa312215-sup-0002){ref-type="supplementary-material"}.
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3.5. Cost trends (USD) in HCM patients with arrhythmias {#joa312215-sec-0012}
-------------------------------------------------------

Among HCM patients with arrhythmias, after adjustment for inflation, HCM hospitalization with arrhythmia claimed \$17599 as total mean cost of care, with a significant rise from \$16105 in 2003 to \$19310 in 2014 (relative increase 22.9%, *P*‐trend \< 0.001). This represents an absolute increment in annual national cost from 125 million dollars in 2003 to 162 million dollars in 2014 (relative increase 34.5%, *P*‐trend \< 0.001). Trends in cost of care among different subgroups of HCM patients are presented in Table [S3](#joa312215-sup-0003){ref-type="supplementary-material"}.

Overall mean cost of HCM hospitalization was consistently higher if patients had any type of arrhythmia compared to no arrhythmia (\$20522 vs \$15636). Across all arrhythmias, the mean cost of care was highest if subjects had VF/VFL (\$39108) and ventricular tachycardia (\$28996), while, the increase in trend of cost of care was highest for supraventricular tachycardia throughout the study period (relative increase 45.4%, *P*‐trend \< 0.04) **(**Table [5](#joa312215-tbl-0005){ref-type="table"} **).** Arrhythmia specific trend in length of hospitalization is shown in Table [S4](#joa312215-sup-0004){ref-type="supplementary-material"}.

###### 

Trends of cost of care as per specific arrhythmia in hospitalized HOCM patients

  Arrhythmia specific Mean Cost in USD (\$)                                  2003     2004     2005     2006     2007     2008     2009     2010     2011     2012     2013     2014     Overall   P‐trend   Relative change
  -------------------------------------------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- --------- -----------------
  Any arrhythmia[a](#joa312215-note-0013){ref-type="fn"}                                                                                                                                                     
  Yes                                                                        19 680   19 141   19 917   19 060   18 856   18 311   22 041   19 807   21 989   21 124   22 866   22 430   20 522    \<0.001   18.3
  No                                                                         13 962   14 733   14 555   14 552   14 585   16 492   16 589   15 912   16 288   16 944   16 858   16 843   15 636    \<0.001   22.1
  Atrial fibrillation[a](#joa312215-note-0013){ref-type="fn"}                                                                                                                                                
  Yes                                                                        19 032   18 435   18 673   17 820   18 073   16 451   20 344   18 457   20 888   19 740   20 697   19 494   19 080    0.004     10.8
  No                                                                         14 729   15 498   15 549   15 557   15 316   17 497   18 070   16 948   17 390   18 183   18 838   19 196   16 836    \<0.001   29.3
  Atrial Flutter[a](#joa312215-note-0013){ref-type="fn"}                                                                                                                                                     
  Yes                                                                        22 173   23 056   26 017   21 394   22 194   19 548   26 785   26 297   26 173   24 299   31 845   32 120   25 676    0.006     38.2
  No                                                                         15 882   16 240   16 195   16 104   15 967   17 065   18 408   17 058   18 238   18 477   18 841   18 513   17 229    \<0.001   20.2
  Supraventricular Tachycardia[a](#joa312215-note-0013){ref-type="fn"}                                                                                                                                       
  Yes                                                                        16 817   20 349   14 331   18 376   15 763   18 385   26 159   26 776   18 756   27 442   15 708   26 444   20 443    0.039     45.4
  No                                                                         16 094   16 398   16 560   16 251   16 225   17 164   18 776   17 332   18 585   18 623   19 596   19 239   17 562    \<0.001   22.6
  Ventricular Fibrillation/Flutter[a](#joa312215-note-0013){ref-type="fn"}                                                                                                                                   
  Yes                                                                        31 412   53 413   50 984   33 983   35 657   25 231   35 173   35 095   38 938   56 450   29 302   46 546   39 108    0.509     2.5
  No                                                                         15 938   16 177   16 361   16 185   16 040   17 103   18 684   17 310   18 403   18 306   19 444   19 002   17 401    \<0.001   22.5
  Ventricular Tachycardia[a](#joa312215-note-0013){ref-type="fn"}                                                                                                                                            
  Yes                                                                        29 163   27 746   26 301   25 967   27 644   26 409   28 526   25 035   30 910   30 311   34 154   33 461   28 996    0.004     20.0
  No                                                                         15 403   15 604   15 958   15 576   15 544   16 481   18 153   16 961   17 674   17 842   18 329   18 154   16 788    \<0.001   21.1

Other primary diagnosis: derived from appropriate ICD 9CM code mentioned in Table [S2](#joa312215-sup-0002){ref-type="supplementary-material"}.
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4. DISCUSSION {#joa312215-sec-0013}
=============

In this study of contemporary data of HCM related hospitalization in USA, we report that over 11 years (2003‐2014), there was an increase in hospitalization rates in patients with HCM and concurrent arrhythmia. Patients 65 years of age or older were admitted most frequently. Overall in HCM, females were dominant over males, and thus had comparatively a higher prevalence of mortality and LOS, however we noted higher prevalence of arrhythmias associated with HCM among male patients compared to females. AF was the most commonly reported arrhythmia and AFL exhibited a substantial increase in prevalence compared to all other arrhythmias. Compared to HCM patients without arrhythmias, inhospital mortality was significantly higher in those with arrhythmia, with VF related SCD as the main contributor in mortality. However, there was a trend towards reduction in mortality throughout the study periods, and in fact the highest mortality reduction occurred in VF victims. The mortality was significantly higher in patients carrying codiagnosis of HF and renal failure. The cost of care increased significantly over the entire study duration, and admissions with renal failure and HF claimed for the highest cost of care. Insignificant reduction in length of stay was noted during study period (Table [S2](#joa312215-sup-0002){ref-type="supplementary-material"}).

Besides endorsing various former studies, these observations highlight some new epidemiological trends in HCM patients. Higher prevalence of HCM among women has been consistently reported in prior reports,[3](#joa312215-bib-0003){ref-type="ref"}, [6](#joa312215-bib-0006){ref-type="ref"}, [19](#joa312215-bib-0019){ref-type="ref"} however, exponential growth among male patients who had concomitant arrhythmia has not been demonstrated before. On the same note, historically HCM is known to be more strongly associated with Blacks,[20](#joa312215-bib-0020){ref-type="ref"} while on contrary, we found higher prevalence of disease in Whites and increment in hospitalization rates among Hispanics. These observations show the contrasting patterns to historical trends[2](#joa312215-bib-0002){ref-type="ref"}, [5](#joa312215-bib-0005){ref-type="ref"}, [8](#joa312215-bib-0008){ref-type="ref"} and clearly demonstrate the evolving penetration of the disease in the general population, affecting patients from both genders and various racial origins. Additionally, we noted that HCM patients admitted non‐emergently (vs emergently) or during weekdays (vs weekends) had higher increment in arrhythmias over years. This population simply represents healthier subgroup who have more room to develop arrhythmias with increasing age and comorbidities.

Although, HCM can present from infancy to old age,[21](#joa312215-bib-0021){ref-type="ref"} it is considered to be prevalent in young and middle age groups[22](#joa312215-bib-0022){ref-type="ref"} with most patients surviving to advanced ages (\>80 years)[23](#joa312215-bib-0023){ref-type="ref"}, [24](#joa312215-bib-0024){ref-type="ref"}. Our study reports lesser mortality in relatively younger age groups and more admission rates among old age patients. These findings validate some of the recently published reports.[25](#joa312215-bib-0025){ref-type="ref"}, [26](#joa312215-bib-0026){ref-type="ref"} Maron et al[25](#joa312215-bib-0025){ref-type="ref"} reported that among 1001 cohorts (30‐59 years), the 5 and 10 year survival rates (confined to HCM related mortality) were 98% and 94%, respectively. The enhanced survival in HCM patients reflects evolution of HCM related treatment strategies and continuum of improved medical practices leading to early cardiac surveillance in high‐risk patients.[4](#joa312215-bib-0004){ref-type="ref"}, [27](#joa312215-bib-0027){ref-type="ref"}, [28](#joa312215-bib-0028){ref-type="ref"}, [29](#joa312215-bib-0029){ref-type="ref"} Detection of high‐risk candidates through improved risk stratification algorithm and diligent application of professional guidelines has led to a more reliable selection of patients who are likely to get mortality benefit from intra cardiac defibrillators (ICDs).[30](#joa312215-bib-0030){ref-type="ref"}, [31](#joa312215-bib-0031){ref-type="ref"}, [32](#joa312215-bib-0032){ref-type="ref"} For instance, in a study by Maron et al,[25](#joa312215-bib-0025){ref-type="ref"} out of 56 high‐risk patients, 33 survived sudden cardiac death (SCD) due to ICD; whereas, SCD occurred in patients who declined ICDs or could not receive prophylactic ICDs. The more frequent use of ICD in right set of candidates along with robust medical care explain the negative trend seen in mortality, with the highest reduction noticed in VF related SCD.

SCD is the most common cause of death in HCM; whereas, HF is reported to be the most common comorbid condition and second most common perpetuator of mortality in these patients.[2](#joa312215-bib-0002){ref-type="ref"}, [33](#joa312215-bib-0033){ref-type="ref"} These findings have been consistently shown in various regional based studies.[5](#joa312215-bib-0005){ref-type="ref"}, [26](#joa312215-bib-0026){ref-type="ref"}, [31](#joa312215-bib-0031){ref-type="ref"} The data utilized from three regional tertiary centers (744 patients) ranked HF as second most common cause of mortality (36%) after SCD.[26](#joa312215-bib-0026){ref-type="ref"} In another analysis of 956 cohorts (follow‐up: 69 ± 45 months), HF related death was second most frequent cause of mortality (21 patients)[5](#joa312215-bib-0005){ref-type="ref"} following SCD. Interestingly, the more recent emerging data represent evolving epidemiological trends and hint towards equilibration of HF with SCD as major contributor of mortality.[25](#joa312215-bib-0025){ref-type="ref"}, [34](#joa312215-bib-0034){ref-type="ref"} Maron et al showed that at 7.2 ± 5.2 years of follow‐up, the mortality rate was 0.23 % per person ‐year in 1000 HCM patients,[25](#joa312215-bib-0025){ref-type="ref"} which was equivalent to mortality rate of SCD (0.23% per person‐year). This paradigm shift is explainable by the extended use of ICD for both primary and secondary prevention of SCD.[26](#joa312215-bib-0026){ref-type="ref"}, [27](#joa312215-bib-0027){ref-type="ref"}, [28](#joa312215-bib-0028){ref-type="ref"}, [30](#joa312215-bib-0030){ref-type="ref"} Encouragingly, we observed a significant decline in HF related death (relative decrease: 33.2 %, *P* \< 0.001) from 2003 to 2014.

AF is the most commonly associated supraventricular arrhythmia in HCM.[35](#joa312215-bib-0035){ref-type="ref"} In analysis of Italian and US cohorts, AF was found be a strong predictor of mortality in HCM (odds ratio (OR): 3.7; *P* \< 0.002) secondary to severe HF related death.[35](#joa312215-bib-0035){ref-type="ref"} This risk was greater in patients \< 50 years of age with left ventricular outlet obstruction. Another Japanese study showed that incidence of AF was most important predictor of cardiovascular mortality in HCM patients.[36](#joa312215-bib-0036){ref-type="ref"} These findings from our analysis are supported by results published in previous studies. Consistent with general reduction in mortality, AF related mortality in HCM has also reduced due to previously discussed better clinical practices which have led to extended longevity in these subsets of patients.

Our study explored the cost burden associated with management of HCM patients with arrhythmias, noting approximately 34.5% rise during the study period. Despite no significant change in the length of hospitalization, healthcare burden significantly rose during the study period approximating 160 million USD per annum. This overwhelming rise in cost of care not only reflects the increasing utilization of expensive technologies such as catheter ablation and devices in the management of these high‐risk subjects but also points towards the growing prevalence of arrhythmias in HCM patients. In the context of ever growing burden on public health and its associated cost of care, these observations are alarming and deserve serious consideration.[37](#joa312215-bib-0037){ref-type="ref"}

5. LIMITATIONS {#joa312215-sec-0014}
==============

This study has limitations inherent to administrative databases. Although administrative databases are increasingly used for representing the scientific information, such studies are prone to errors secondary to coding inaccuracies. HCM and related comorbidities were diagnosed based on administrative codes. Therefore, there is a possibility that we might have missed some information, leading to under estimation of the number of hospitalizations. Given the nature of the data, we could only examine inhospital mortality; hence, the study lacks the assessment of long‐term follow‐up outcomes.

6. CONCLUSION {#joa312215-sec-0015}
=============

Our study reports rise in hospitalization as a result of arrhythmias in HCM patients as well as concurrent increase in mortality and resource utilization over study period. We believe that this study represents new epidemiological trends. Furthermore, inclusion of a "real‐world" large sample size and the absence of selection bias have strengthened the validity of the outcomes.
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